ScopusElsevier Scopus
Status
Active
Coverage
2015–present
Source type
Journal
Open access
No
CiteScore
71.3
SJR · SCImago
15.606
Q1 SJR quartile
H-index
236
Best quartile
Q1 · 99th pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 5 / 669 | 99th | Q1 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nature Reviews Disease Primers
Nature Reviews Disease Primers is Scopus-indexed (Q1, CiteScore 71.3), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Nature Publishing Group.
Checked against the index lists dated .
ISSN 2056-676XVerify ISSN ↗
Publisher: Nature Publishing Group
Scopus · Q1WoS · SCIEONOS
71.3
CiteScore 2025
Q1
Best quartile
2
Indexed in
Cost to publish: No APC data — check the publisher
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
ONOS · SubscriptionOne Nation One Subscription — full-text access
This journal is part of the ONOS national subscription — readers at an ONOS-subscribed Indian institution get full-text access to its articles at no cost.
Access depends on your institution’s ONOS participation; the subscribed title list is subject to revision.
Learn about ONOS Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Quick answers
Is Nature Reviews Disease Primers indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2015–present, best quartile Q1, CiteScore 71.3.
What quartile is Nature Reviews Disease Primers in Scopus?
Nature Reviews Disease Primers is Q1 in Medicine (all) (rank 5 of 669), by CiteScore 2025.
What is the impact factor of Nature Reviews Disease Primers?
Nature Reviews Disease Primers is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 71.3, which places it in quartile Q1 at the 99th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 15.606, quartile Q1, with an H-index of 236.
Who publishes Nature Reviews Disease Primers and what is its ISSN?
Nature Reviews Disease Primers is published by Nature Publishing Group. Its ISSN is 2056-676X.
Is Nature Reviews Disease Primers covered under ONOS in India?
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Is Nature Reviews Disease Primers in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Nature Reviews Disease Primers open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Nature Reviews Disease Primers? — open metrics via OpenAlex
Nature Reviews Disease Primers has an h-index of 279 and a 2-year mean of 38.02 citations per paper (OpenAlex). Its Scopus CiteScore is 71.3, quartile Q1. On 2-year citations it ranks #1 of 646 Scopus journals in Medicine (all).
279
h-index
38.02
2-yr mean citations
616
i10-index
1,078
works indexed
281,162
total citations
2-yr mean citations, among Scopus journals in the same subject
#1 of 646 Top 1% Medicine (all)
Nature Reviews Disease Primers published 92 papers in 2025; its busiest recent year was 2017 with 106. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Nature Reviews Disease Primers? — latest 53 articles, 2025–2026
In its latest 53 research articles (2025–2026), authors are most often from United States (22.7%), United Kingdom (8.9%) and Australia (5.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Nature Reviews Disease Primers? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journals Journal Indexed in
Nature Reviews Endocrinology Scopus Q1 WoS SCIE Nature Reviews Materials Scopus Q1 WoS SCIE Nature Reviews Psychology Scopus Q1 WoS SSCI Nature Structural Biology Not in these indexes Nature Sustainability Scopus Q1 WoS SCIE/SSCI Nature Synthesis Scopus Q1 WoS ESCI NPG Asia Materials Scopus Q1 WoS SCIE DOAJ npj 2D Materials and Applications Scopus Q1 WoS SCIE DOAJ
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.